Balloon assembly provided with guide wire channel and used for dosing prostate

By designing the balloon catheter and sheath system of the olive balloon assembly, combined with paclitaxel administration, the long-term and complications of prostate hyperplasia surgery were solved, the precise expansion of the prostate and inhibit re-hyperplasia was achieved, and the surgical process was simplified. Improves safety and effectiveness.

CN221932829UActive Publication Date: 2024-11-01启维医疗技术(深圳)有限责任公司
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202322637117.8
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-09-27
Publication Date
2024-11-01
Estimated Expiration
2033-09-27

AI Technical Summary

Technical Problem

The existing prostate hyperplasia surgery methods have problems such as long surgery time, many bleeding, many complications, and multiple surgeries from patients, which is difficult to effectively solve the problems of prostate stenosis and urethral obstruction.

Method used

A prostate drug delivery balloon assembly containing an olive balloon was designed. Through the combination of the balloon catheter and the sheath, the independent booster fluid channel of the positioning balloon and the olive balloon are used to achieve precise expansion of the prostate and When administering drugs, use paclitaxel and other drugs to inhibit cell proliferation and avoid re-stenosis.

Benefits of technology

It has achieved simplified surgical procedures, shortened surgical time, improved safety and effect, avoided external urethral sphincter damage, and ensured that patients urinate normally.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN221932829U_ABST
    Figure CN221932829U_ABST
Patent Text Reader

Abstract

The balloon assembly comprises a balloon catheter, a positioning balloon, an olive-shaped balloon, a pressurizing liquid channel, the guide wire channel and the like, the positioning balloon plays a role in positioning, the stability of an operation is improved, and the guiding wire channel is arranged on the balloon catheter. A medicine composition is arranged on the outer surface of the olive-shaped balloon and makes contact with an area needing to be treated in the operation process. The balloon assembly is combined with an existing instrument to treat prostate diseases, the narrow urethra of the benign hyperplasia section of the prostate can be safely expanded, restenosis of the urinary tract is reduced, and the purpose that a patient normally urinates is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medical technology, in particular to a balloon component with a guide wire channel for administering drugs to the prostate, also known as a prostate drug coating dilatation catheter set. Background Art

[0002] Prostatic hyperplasia is one of the common diseases in middle-aged and elderly men, and the incidence is increasing with the aging of the global population. Its symptoms include frequent urination, urgency, waiting to urinate, difficulty urinating, prolonged urination time, and a series of other symptoms. Currently common surgical methods include: transurethral resection of the prostate (TURP), transurethral prostatic urethral dilation (Urolift), transurethral thermal ablation, etc. However, there are many problems that need to be overcome with today's surgical methods, such as: long operation time, long hospitalization time after surgery, heavy bleeding during surgery, a series of complications during surgery, etc. Patients often need multiple surgeries to ensure normal urination. Utility Model Content

[0003] The prostate drug balloon assembly is a new technology. This technology uses paclitaxel or other drugs to apply on the surface of a special balloon, and then inserts the balloon into the patient's bladder and prostate through the urethra. After full expansion, it eliminates the urethral stenosis of the prostate hyperplasia part, and can inhibit the proliferation of paclitaxel to prevent the prostate from proliferating again, leading to restenosis of the urethra, so that patients can urinate normally. Using the prostate balloon assembly as a device to solve the problem of prostate stenosis is a new and safe treatment method.

[0004] The present application discloses a drug-delivery balloon assembly, which uses a balloon surface coated with medicine and is placed in the prostate and bladder through the urethra to treat prostate hypertrophy and solve the problem of urination difficulties.

[0005] The technical solution disclosed in this application includes the following implementation methods:

[0006] Embodiment 1: A prostate drug delivery balloon assembly containing an olive-shaped balloon, also referred to as a balloon assembly for delivering drugs to the prostate with a guidewire channel, comprising:

[0007] A balloon catheter, a positioning balloon fixedly arranged at the distal end of the balloon catheter, and an olive-shaped balloon adjacent to the positioning balloon and fixedly arranged on the balloon catheter.

[0008] The balloon catheter has a guidewire channel and a pressurized liquid channel, wherein the pressurized liquid channel is connected to the positioning balloon and the olive-shaped balloon, and the guidewire channel is not connected to the pressurized liquid channel.

[0009] The drug delivery balloon assembly further comprises a sheath tube for accommodating the positioning balloon, the olive-shaped balloon and a corresponding balloon catheter, so that the positioning balloon and the olive-shaped balloon can reciprocate in the sheath tube, and the outer diameter of the sheath tube is 2 mm to 10 mm, preferably 4 mm to 8 mm, or 5 mm to 7 mm.

[0010] A drug composition layer is disposed on the outer surface of the olive-shaped balloon,

[0011] Wherein, the positioning balloon is used to be arranged in the patient's bladder for positioning the balloon catheter, the olive-shaped balloon is used to be arranged in the patient's prostate for dilating and administering drugs to the prostate by contacting the inner wall of the prostate, the length of the sheath is greater than the length of the balloon catheter in the patient's body when in use, and is less than the length of the balloon catheter, and when the sheath is withdrawn proximally relative to the balloon catheter, at least the positioning balloon and the olive-shaped balloon are exposed. In this application, the term "olive-shaped balloon" refers to a "drug administration balloon" used to be accommodated in the prostatic urethra for contact administration to the prostate, therefore, the term "olive-shaped balloon" in this application has the same meaning as the term "drug administration balloon", both of which refer to a balloon adjacent to the positioning balloon, which is olive-shaped, with a drug composition disposed on the outer surface, and is used to be accommodated in the prostatic urethra for contact administration to the prostate.

[0012] Embodiment 2: The balloon assembly according to embodiment 1, further comprising a balloon connecting portion disposed between the positioning balloon and the olive-shaped balloon, wherein the outer diameter of the balloon connecting portion is smaller than the outer diameters of the positioning balloon and the olive-shaped balloon.

[0013] Embodiment 3: According to the balloon assembly described in embodiment 1, the positioning balloon and the olive-shaped balloon are directly connected, and there is no balloon connection portion between the two balloons. In this application, the term "balloon connection portion" is also referred to as "balloon neck", and the two terms have the same meaning and can be used interchangeably, both referring to a connection portion that may exist between the two balloons, and the connection portion is neither a positioning balloon nor an olive-shaped balloon in shape.

[0014] Embodiment 4. The balloon assembly according to embodiment 1, wherein the pressurized fluid channel comprises a positioning balloon pressurized fluid channel and an olive-shaped balloon pressurized fluid channel, the positioning balloon pressurized fluid channel and the olive-shaped balloon pressurized fluid channel are not connected to each other, the positioning balloon pressurized fluid channel has a positioning balloon pressurized fluid channel through hole connected to the positioning balloon, and the olive-shaped balloon pressurized fluid channel has an olive-shaped balloon pressurized fluid channel through hole connected to the olive-shaped balloon.

[0015] Embodiment 5. A balloon assembly according to embodiment 1, wherein the sheath has a sheath front portion and a sheath rear portion, the sheath front portion is made of a low-strength material, the length of the sheath front portion is greater than 2 mm and shorter than the distance between two balloons, and the sheath rear portion is made of a high-strength material, so that when the positioning balloon and the olive-shaped balloon are in the sheath rear portion, the balloons cannot be expanded by applying pressure.

[0016] Embodiment 6: The balloon assembly according to embodiment 1 or 5, wherein the inner diameter of the sheath tube is such that when the positioning balloon and the olive-shaped balloon are expanded and then contracted under the pressure of the pressurized fluid, the positioning balloon and the olive-shaped balloon can be retracted into the sheath tube.

[0017] Embodiment 7: A balloon assembly according to embodiment 1, wherein the longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon independently have convex arc-shaped contours at the ends.

[0018] Embodiment 8: According to the balloon assembly of embodiment 1, the longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon independently form an angle of 30 to 50 degrees with the balloon catheter at the end.

[0019] Embodiment 9: The balloon assembly according to embodiment 1, wherein the drug composition layer contains at least one of paclitaxel and rapamycin, and an optional drug carrier.

[0020] Embodiment 10, according to any one of embodiments 1-7, wherein the radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 6-40 mm, such as 10 to 35 mm, such as 12 to 30 mm, such as 15 to 25 mm, such as 16 to 23 mm.

[0021] Embodiment 11. A balloon assembly according to any one of embodiments 1 to 10, wherein the positioning balloon and the olive-shaped balloon are both non-compliant balloons or low-compliant balloons.

[0022] When a prostate drug delivery balloon assembly containing an olive-shaped balloon in the above embodiment is used to treat prostate hyperplasia, it is only necessary to make the olive-shaped balloon in the balloon assembly contact and expand the urethra wrapped in the prostate (also called prostate urethra) to complete the operation, and the treatment process is simple and safe. The drug delivery balloon is set in an olive shape, which matches the shape of the prostate urethra in a healthy state, so that the prostate urethra can be properly expanded and the prostate can be inhibited from hyperplasia again by contact drug delivery; the olive-shaped balloon tip design can also prevent damage to the external urethral sphincter. Some embodiments are provided with separate pressurized liquid channels for positioning balloons and olive-shaped balloons, and the pressurization of the two balloons is completely independent, with strong controllability, easy positioning, and greatly shortening the operation time. In some embodiments, the two balloon ends are set at an angle with the balloon catheter, made of non-compliant materials, and the balloon is easy to be collected into the balloon sheath after the drug delivery, which can further improve the safety of the operation and ensure excellent surgical results. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the technical solutions of the embodiments of the present disclosure, the drawings of the embodiments will be briefly introduced below. Obviously, the drawings in the following description only relate to some embodiments of the present disclosure, but are not intended to limit the present disclosure.

[0024] Figure 1 A schematic diagram showing that both the positioning balloon and the olive-shaped balloon described in Example 1 are not expanded;

[0025] Figure 2 A schematic diagram showing the positioning balloon after expansion in Example 1 is shown;

[0026] Figure 3 A schematic diagram showing the positioning balloon and the olive-shaped balloon described in Example 1 after both are expanded;

[0027] Figure 4 A schematic diagram showing independent pressurization of the positioning balloon and the olive-shaped balloon described in Example 2;

[0028] Figure 5 A schematic diagram of a cross section of the balloon catheter described in Example 2 is shown;

[0029] Figure markings: 1-balloon catheter, 2-positioning balloon, 3-olive-shaped balloon, 4-sheath, 5-pressurizing fluid channel, 6-guidewire channel, 7-front of balloon catheter, 8-rear of balloon catheter, 9-positioning balloon pressurizing fluid channel, 10-olive-shaped balloon pressurizing fluid channel, 11-positioning balloon pressurizing fluid channel through hole, 12-olive-shaped balloon pressurizing fluid channel through hole, 13-balloon catheter grid. DETAILED DESCRIPTION

[0030] In order to make the purpose, technical solution and advantages of the embodiments of the present disclosure clearer, the technical solution of the embodiments of the present disclosure will be clearly and completely described below in conjunction with the drawings of the embodiments of the present disclosure. Obviously, the described embodiments are part of the embodiments of the present disclosure, not all of the embodiments. Based on the described embodiments of the present disclosure, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present disclosure.

[0031] The following terms have specific meanings in this application:

[0032] In the present application, the direction along the catheter is defined as “longitudinal”, and the direction perpendicular to the catheter is defined as “radial”. The balloon mainly expands in the radial direction.

[0033] In the present application, the part that first reaches the area to be processed during use is defined as the "front", and the direction opposite to the "front" is defined as the "rear".

[0034] In this application, unless otherwise specified or different meanings can be derived from the context, each term has the meaning commonly understood in the art.

[0035] The present application discloses a prostate drug delivery balloon assembly containing an olive-shaped balloon, which comprises: a balloon catheter, a positioning balloon fixedly arranged at the distal end of the balloon catheter, and an olive-shaped balloon adjacent to the positioning balloon and fixedly arranged on the balloon catheter, the balloon catheter having a guide wire channel and a pressurizing liquid channel, wherein the pressurizing liquid channel is connected with the positioning balloon and the olive-shaped balloon, and the guide wire channel is not connected with the pressurizing liquid channel, the drug delivery balloon assembly also comprises a sheath tube for accommodating the positioning balloon, the olive-shaped balloon and the corresponding balloon catheter, so that the positioning balloon and the olive-shaped balloon can reciprocate in the sheath tube, The outer diameter of the sheath is 2mm to 10mm, preferably 4mm to 8mm, or 5mm to 7mm, and a drug composition layer is arranged on the outer surface of the olive-shaped balloon, wherein the positioning balloon is used to be arranged in the patient's bladder for positioning the balloon catheter, and the olive-shaped balloon is used to be arranged in the patient's prostate for dilating and administering the prostate by contacting the inner wall of the prostate, and the length of the sheath is greater than the length of the balloon catheter in the patient's body when in use, and is less than the length of the balloon catheter, and when the sheath is withdrawn to the proximal end relative to the balloon catheter, at least the positioning balloon and the olive-shaped balloon are exposed. The setting of the guidewire channel enables the balloon catheter to reach the selected area to be treated along the guidewire under the guidance of the guidewire for treatment. During treatment, the guidewire is first set, and then the sheath is set with the help of the sheath core, and then the sheath core is withdrawn, and then the balloon catheter is set through the sheath, that is, the balloon is pushed to the desired position. It should be noted that the sheath core used when setting the sheath has the meaning generally understood by those skilled in the art, and is used to be nested in the sheath to assist the sheath to enter the body safely. When the balloon catheter enters the area to be treated along the urethra, the sheath is pulled toward the rear of the balloon catheter to expose the positioning balloon, and then the pressurizing liquid is injected into the positioning balloon through the pressurizing liquid channel, and after the positioning balloon is fully expanded, the positioning balloon is positioned exactly in the patient's bladder. Then, the sheath is continued to be pulled toward the rear of the balloon catheter until the olive-shaped balloon is exposed, and at this time, the pressurizing liquid is continued to be injected into the pressurizing liquid channel until the olive-shaped balloon is fully expanded. After the drug on the surface of the olive-shaped balloon is administered to the surface of the prostate, the pressurizing liquid is extracted through the pressurizing liquid channel, and negative pressure is generated in the positioning balloon and the olive-shaped balloon. Under the action of the negative pressure, the positioning balloon and the olive-shaped balloon are contracted and folded, and the sheath is moved so that the balloon is completely stored in the sheath to prevent tingling and injury to the human body when the balloon catheter is pulled backwards. Finally, the sheath and the balloon catheter are withdrawn from the human body at the same time to complete the treatment.The outer diameter of the sheath described in the present application ranges from 2 mm to 10 mm, preferably from 4 mm to 8 mm, or from 5 mm to 7 mm, and the inner diameter is substantially close to the outer diameter, and is usually 0.3 to 0.6 mm smaller than the outer diameter, so that the balloon catheter with the balloon can move in the sheath. The balloon catheter can enter the human body through the sheath during treatment, and after the treatment is completed, the balloon is retracted into the sheath, so that the balloon catheter can be withdrawn smoothly.

[0036] In some embodiments, a balloon neck portion is further included between the positioning balloon and the olive-shaped balloon, and the outer diameter of the balloon neck portion is smaller than the outer diameters of the positioning balloon and the olive-shaped balloon. The neck portion with a smaller diameter can anchor the olive-shaped balloon and the positioning balloon more firmly in the body cavity, thereby preventing the balloon from sliding freely in the body cavity. If the olive-shaped balloon slides or leaves the lesion site, it may cause injury to the healthy lumen.

[0037] In some embodiments, the positioning balloon and the olive-shaped balloon are directly connected, and there is no neck between the two balloons. There is no neck between the positioning balloon and the olive-shaped balloon. The "no neck between the two balloons" mentioned in this application means that the positioning balloon and the olive-shaped balloon are directly connected, without a neck connection surface, and when the two balloons are fully expanded, the outer contour lines of the connection between the two balloons are directly intersected by the balloon expansion arcs.

[0038] In some embodiments, the pressurized liquid channel includes a positioning balloon pressurized liquid channel and an olive-shaped balloon pressurized liquid channel, the positioning balloon pressurized liquid channel and the olive-shaped balloon pressurized liquid channel are not connected to each other, the positioning balloon pressurized liquid channel has a positioning balloon pressurized liquid channel through hole connected to the positioning balloon, and the olive-shaped balloon pressurized liquid channel has an olive-shaped balloon pressurized liquid channel through hole connected to the olive-shaped balloon. Through the connection between the positioning balloon and the positioning balloon pressurized liquid channel, and the olive-shaped balloon and the olive-shaped balloon pressurized liquid channel, the separate pressurization control of the positioning balloon and the olive-shaped balloon is achieved. By means of separate control, the expansion of the two balloons can be achieved without affecting each other, avoiding excessive expansion of one balloon and causing damage to the human body. After the treatment is completed, the pressurized liquid can also be extracted from the two balloons respectively to achieve orderly contraction and folding to prevent damage to the human body.

[0039] In some embodiments, the sheath has a sheath front and a sheath rear, the sheath front is made of low-strength material, the length of the sheath front is greater than 2mm and shorter than the distance between the two balloons, and the sheath rear is made of high-strength material, so that when the positioning balloon and the olive-shaped balloon are in the sheath rear, the balloon cannot be expanded by pressurization. The distance between the two balloons described in this application is the minimum distance between the parts with radial dimensions greater than 12mm after the two balloons are expanded. The purpose of this setting is to set a certain length of the sheath front made of low-strength material to ensure that the human body is not damaged. The application further limits the longest distance of the sheath front to prevent the olive-shaped balloon from expanding during the first pressurization. The low-strength material used in the sheath front is made of, such as silica gel, so that when the sheath is inserted into the urethra, prostate, and bladder, it is not easy to damage human organ tissue. After the application of the medicine, the low-strength material is easy to receive the balloon in the sheath front, which can ensure that the two balloons will be smoothly collected in the sheath in sequence. The rear part of the sheath is made of high-strength material, such as PVC material, to ensure that the olive-shaped balloon does not expand when the pressure is first applied, so as to prevent damage to the urethra, prostate, and bladder. It should be noted that the high-strength material and low-strength material described in this application are relative to the human body use environment. When the material is used to make the device described in this application and is used in the human body, the material with high strength and capable of withstanding the pressure of the boosting fluid is called a high-strength material. On the contrary, when the material is used to make the device described in this application and is used in the human body, the material with low strength and not easy to cause damage to the human body is called a low-strength material.

[0040] In some embodiments, the inner diameter of the sheath is such that when the positioning balloon and the olive-shaped balloon are expanded and then contracted under the pressure of the pressurized fluid, the positioning balloon and the olive-shaped balloon can be retracted into the sheath. If the positioning balloon and the olive-shaped balloon are not retracted into the sheath after contraction and are directly pulled out of the body, not only may the pulling cause damage to the human body, but the residual drug may also be smeared into the area where the balloon passes, causing damage to other tissues. Therefore, it is necessary to set the diameter of the sheath within a reasonable range so that the balloon can be easily inserted into the sheath.

[0041] In some embodiments, the longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon each independently have a convex arc-shaped profile at the end. The structure of the end having a convex arc-shaped profile is adapted to the structure of the human body, and avoids damage to the bladder or prostate when the booster fluid channel is pressurized. When pressurized, the balloon can slide slightly appropriately, thereby effectively avoiding damage to the external urethral sphincter when the balloon is expanded.

[0042] In some embodiments, the longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon are independently at an angle of 30 to 50 degrees with the balloon catheter at the end. The feature that the end of the balloon is at an angle of 30 to 50 degrees with the balloon catheter is adapted to the structure of the human body. The range of 30 to 50 degrees is the most suitable range. If the angle is too large, the shape of the balloon will not match the shape of the prostatic urethra, affecting the drug administration effect; when the angle is too small, it will cause the balloon to be difficult to expand after pressurization to stretch the patient's prostate to obtain enough space, affecting the surgical effect, and it is not easy to have a slight sliding adaptive effect, which is easy to damage the external urethral sphincter. The angle here refers to the angle between the surface of the balloon located at a radial dimension of 12 mm and the balloon catheter when the balloon is expanded.

[0043] In some embodiments, the drug composition layer contains at least one of paclitaxel and rapamycin, and an optional drug carrier. The drug carrier preferably includes a hydrophilic drug carrier and / or a hydrophobic drug carrier. In some embodiments, the drug carrier is selected from at least one of iopamidol, iopromide, PEG, and PVP. The existing drug-coated balloon interventional therapy technology attaches drugs that inhibit cell proliferation to the balloon surface, and through the expansion of the balloon, the drug surface is attached to the diseased area to achieve the effect of directly administering drugs to the diseased area to inhibit proliferation. Both paclitaxel and rapamycin have the effect of inhibiting cell proliferation, and are widely used in clinical treatment fields such as anti-cancer. Both of these drugs are lipophilic drugs, and the lipophilic drugs paclitaxel and / or rapamycin are arbitrarily combined with the hydrophilic drug carrier to form the drug composition, and the hydrophilic drug carrier can form a coating with a high contact surface between the lipophilic drug molecules and the prostate, enhance the dissolution and release of the lipophilic drug molecules, and may change drug delivery and its interaction with tissues. The drug composition is loaded on the surface of the olive-shaped balloon as a balloon coating. After the olive-shaped balloon is expanded, the loaded drug composition is in complete contact with the area to be treated, and the target drug dose is evenly and rapidly released. Clinical experience shows that a short contact time of only 10 minutes is sufficient to fully administer the drug, inhibit cell proliferation, and prevent prostate cell hyperplasia.

[0044] In the present application, the coating position of the pharmaceutical composition is not particularly limited. It should be understood by those skilled in the art that the pharmaceutical composition is mainly coated on the olive-shaped balloon. In some embodiments, the pharmaceutical composition is also coated on the positioning balloon, for example, coated on the side of the positioning balloon facing the olive-shaped balloon. In some embodiments, the pharmaceutical composition can also be coated on the connecting portion of the positioning balloon and the olive-shaped balloon, and the coating drug here is mainly used to treat the internal urethral sphincter.

[0045] In some embodiments, the radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 6-40 mm, such as 10 to 35 mm, such as 12 to 30 mm, such as 15 to 25 mm, such as 16 to 23 mm. The radial dimension of the balloon is directly related to the positioning effect of the positioning balloon and whether it will cause prostate or bladder damage. When the radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are too large, the injection of pressurized liquid causes the balloon to expand. Due to the excessive radial dimensions of the balloon, the bladder and prostate are over-expanded from the inside, which is prone to complications such as urethral hemorrhage. When the radial dimension of the balloon is small, the positioning balloon cannot be accurately positioned, causing the olive-shaped balloon to move back and forth after expansion, and it is impossible to accurately administer medication to the affected area, and it is impossible to fully expand the prostate part that causes urethral stenosis. Affected by individual differences, the selection of a balloon with a suitable radial dimension depends on early medical observations and diagnoses. In addition, the longitudinal dimensions of the positioning balloon and the olive-shaped balloon are independently 20-60 mm, such as 30 to 50 mm, such as 20 to 30 mm, 30 to 40 mm. Similarly, affected by individual differences, the selection of a balloon with a suitable longitudinal dimension depends on early medical observation and diagnosis.

[0046] In some embodiments, the positioning balloon and the olive-shaped balloon are both non-compliant balloons or low-compliant balloons. The compliance of the balloon is mainly reflected in the ability of the balloon diameter to change with pressure. The compliance of the balloon is closely related to the material. Commonly used materials include nylon and special polyethylene, which have good physical properties such as ultra-thin thickness, low compliance, and high pressure resistance. Non-compliant and low-compliant balloons ensure the safety of patients and prevent excessive expansion of the balloon, which may cause accidental injury to the patient's prostate or bladder.

[0047] The balloon can be manufactured by blow molding or other molding processes, and can include materials that do not interact with the drug coating or materials such as the following: nylon, polyether block amide (PEBA), polyvinyl chloride (PVC), polyester, polyurethane, derivatives thereof, or combinations thereof. The balloon and the catheter can be combined together by hot melting or by bonding with a suitable adhesive. There is no particular limitation on the materials and methods for making the balloon assembly, and those skilled in the art can select according to actual needs.

[0048] The above ranges can be used alone or in combination. The present application can be more easily understood through the following examples.

[0049] Example

[0050] Example 1

[0051] like Figure 1-3As shown, a prostate drug delivery balloon assembly containing an olive-shaped balloon in this embodiment includes: the balloon catheter 1, a positioning balloon 2 fixedly arranged at the distal end of the balloon catheter 1, and an olive-shaped balloon 3 adjacent to the positioning balloon 2 and fixedly arranged on the balloon catheter 1, the positioning balloon and the olive-shaped balloon are directly connected and do not have a neck connection surface.

[0052] The balloon catheter 1 has a guidewire channel 6 and a pressurized liquid channel 5, wherein the pressurized liquid channel 5 is connected to the positioning balloon 2 and the olive-shaped balloon 3, and the guidewire channel 6 is not connected to the pressurized liquid channel 5.

[0053] The drug delivery balloon assembly further comprises a sheath tube 4 for accommodating the positioning balloon 2, the olive-shaped balloon 3 and the corresponding balloon catheter 1, so that the positioning balloon 2 and the olive-shaped balloon 3 can reciprocate in the sheath tube 4, and a drug composition layer is arranged on the outer surface of the olive-shaped balloon 3.

[0054] Among them, the positioning balloon 2 is used to be set in the patient's bladder for positioning the balloon catheter 1, the olive-shaped balloon 3 is used to be set in the patient's prostate for dilating and administering the prostate by contacting the inner wall of the prostate, the length of the sheath 4 is greater than the length of the balloon catheter 1 in the patient's body when in use, and is less than the length of the balloon catheter 1, and ensures that when the sheath 4 is withdrawn proximally relative to the balloon catheter 1, at least the positioning balloon 2 and the olive-shaped balloon 3 are exposed.

[0055] The length of the balloon catheter 1 is 500mm, and the length in the patient's body during treatment is 250mm. The length of the balloon catheter 1 is greater than the length in the patient's body to ensure the operation space outside the body. The outer diameter of the sheath tube 4 is 4mm and the length is 300mm. The 3mm in front of the sheath tube of the sheath tube is made of silicone. The outer diameter of the sheath tube 4 is set to 4mm, which is enough to accommodate the positioning balloon 2, the olive-shaped balloon 3 and the balloon catheter 1, so that it can be stored after the drug administration is completed. The front of the sheath tube of the sheath tube is 3mm and is made of silicone. It is not easy to scratch human organs and tissues, and it is also conducive to storage after the drug administration is completed. The positioning balloon 2 is made of nylon 66 and has non-compliance. Its radial dimension is 30mm when expanded, and it is at an angle of 40 degrees with the balloon catheter 1 at the end. The olive-shaped balloon 3 is made of nylon 66 and is also non-compliant. The radial dimension during expansion is 30mm, and it is at an angle of 30 degrees with the balloon catheter 1 at the end. The non-compliant material is selected, there is no neck between the two balloons, and they are directly made by one-piece blow molding, which ensures that the balloon will not continue to expand after pressurization, greatly improving the safety of the operation. The positioning balloon 2 and the olive-shaped balloon 3 are at an angle of 40 degrees with the balloon catheter 1 at the end, which is easy to slide and avoids damaging the internal urethral sphincter and the external urethral sphincter.

[0056] The method used in this embodiment is as follows:

[0057] First, a guide wire is set, and then a sheath is introduced, and its front section is observed to be located in the bladder under B-ultrasound, and then the prostate drug delivery balloon assembly with an olive-shaped balloon is inserted from the tail of the guide wire until it penetrates to the front section of the guide wire, so that the prostate drug delivery balloon assembly containing the olive-shaped balloon is positioned.

[0058] like Figure 1-2 As shown, the sheath tube 4 is moved toward the rear portion 8 of the balloon catheter until the positioning balloon 2 is completely exposed, at which time the movement of the sheath tube 4 is stopped, and the positioning balloon 2 is pressurized through the pressurizing fluid channel 5. After the positioning balloon 2 is fully expanded, the pressurization is stopped. The balloon catheter 1 is gently pulled, and when a slight resistance is felt, it indicates that the positioning balloon 2 is located at the bladder opening close to the prostate, and the positioning is completed.

[0059] like Figure 3 As shown, the sheath tube 4 continues to move along the balloon catheter 1 toward the rear portion 8 of the balloon catheter until the olive-shaped balloon 3 is completely exposed, and the outer surface of the olive-shaped balloon 3 is evenly provided with a drug composition layer composed of paclitaxel and iopromide with a thickness of about 50 microns. The olive-shaped balloon 3 is pressurized through the pressurizing liquid channel 5 until the olive-shaped balloon 3 is fully expanded. The drug composition layer on the surface of the olive-shaped balloon 3 contacts the prostate diseased area, expands the urethral stricture area, and quickly releases the drug to the contacted area. After reaching the predetermined expansion time, the pressurizing liquid is extracted through the pressurizing liquid channel 5, and the sheath tube 4 is moved toward the front portion 7 of the balloon catheter, so that the pressure-free positioning balloon 2 and the olive-shaped balloon 3 are received in the sheath tube 4. Finally, the prostate drug delivery balloon assembly containing the olive-shaped balloon is completely withdrawn to end the treatment.

[0060] The use of a prostate drug delivery balloon treatment containing an olive-shaped balloon in this embodiment can greatly shorten the operation time. The operation can be completed only by contacting the balloon with the prostate, and the treatment process is simple. In addition, the two balloon ends are arranged at an angle of 40 degrees with the balloon catheter 1, are made of non-compliant materials, and the balloon is retracted into the balloon sheath after the drug delivery is completed, which can improve the safety of the operation and ensure excellent surgical results.

[0061] Example 2

[0062] like Figure 4-5As shown, the connection relationship between the various components in this embodiment and in Example 1 is basically the same, the difference is that the pressurized liquid channel 5 in Example 1 is divided into a positioning balloon pressurized liquid channel 9 and an olive-shaped balloon pressurized liquid channel 10 by a balloon catheter grid 13, and correspondingly, a positioning balloon pressurized liquid channel through hole 11 and an olive-shaped balloon pressurized liquid channel through hole 12 are respectively added on the surface of the balloon catheter 1.

[0063] The method used in this embodiment is as follows:

[0064] First, a guide wire is set, and then a sheath is introduced. Its front section is observed to be located in the bladder under B-ultrasound. Then, the prostate drug delivery balloon assembly containing an olive-shaped balloon is inserted from the tail of the guide wire until it penetrates into the front section of the guide wire.

[0065] The positioning balloon 2 and the olive-shaped balloon 3 are respectively mounted and fixed on the balloon catheter 1, and the two balloons are not connected to each other. The positioning balloon 2 is pressurized through the positioning balloon pressurizing liquid channel 9, and the olive-shaped balloon 3 is pressurized through the olive-shaped balloon pressurizing liquid channel 10. The positioning balloon pressurizing liquid channel 9 and the olive-shaped balloon pressurizing liquid channel 10 are provided with a balloon catheter grid 13 before them, and the two pressurizing channels are not connected to each other.

[0066] like Figure 4 As shown, the sheath tube 4 is moved toward the rear part 8 of the balloon catheter until the positioning balloon 2 is completely exposed, at which time the movement of the sheath tube 4 is stopped, and the positioning balloon 2 is pressurized through the positioning balloon pressurizing liquid channel 9. At this time, there is no pressure inside the olive-shaped balloon 3. After the positioning balloon 2 is fully expanded, the pressurization is stopped. Gently pull the balloon catheter 1. When a slight resistance is felt, it means that the positioning balloon is located at the bladder opening close to the prostate, and the positioning is completed. Move the sheath tube 4 toward the rear part 8 of the balloon catheter until the olive-shaped balloon 3 is completely exposed, and the olive-shaped balloon 3 is pressurized through the olive-shaped balloon pressurizing liquid channel 10. Due to the presence of the balloon grid 13, independent pressure control of the positioning balloon 2 and the olive-shaped balloon 3 can be achieved. After the positioning balloon 2 and the olive-shaped balloon 3 are fully expanded, the pressurization is stopped. At this time, the positioning balloon 2 and the olive-shaped balloon 3 cannot move.

[0067] The outer surface of the olive-shaped balloon 3 is evenly provided with a drug composition layer composed of paclitaxel, iopromide, PEG or PVP with a thickness of about 50 microns. The drug composition layer on the surface of the olive-shaped balloon 3 contacts the diseased area of ​​the prostate, expands the urethral stenosis area, and quickly releases the drug to the contacted area. After reaching the predetermined expansion time, the pressurizing liquid is extracted through the positioning balloon pressurizing liquid channel 9 and the olive-shaped balloon pressurizing liquid channel 10, and the sheath 4 is moved toward the front part 7 of the balloon catheter, so that the pressure-free positioning balloon 2 and the olive-shaped balloon 3 are received in the sheath 4. Finally, the prostate drug delivery balloon assembly containing the olive-shaped balloon is completely withdrawn to end the treatment.

[0068] The length of the balloon catheter 1 is 500mm, and the length in the patient's body during treatment is 300mm. The length of the balloon catheter 1 is greater than the length in the patient's body to ensure the operation space outside the body. The outer diameter of the sheath tube 4 is 12mm and the length is 350mm. The front 2mm of the sheath tube of the sheath tube is made of silicone. The outer diameter of the sheath tube 4 is set to 5mm, which is enough to accommodate the positioning balloon 2, the olive-shaped balloon 3 and the balloon catheter 1, so that it can be stored after the drug administration is completed. The front part of the sheath tube of the sheath tube is 2mm and is made of silicone. It is not easy to scratch human organs and tissues, and it is also conducive to storage after the drug administration is completed. The positioning balloon 2 is made of nylon 66 and has non-compliance. Its radial dimension is 30mm when expanded, and it is at an angle of 45 degrees with the balloon catheter 1 at the end. The olive-shaped balloon 3 is made of nylon 66 and is also non-compliant. The radial dimension is 30mm when expanded, and it is at an angle of 45 degrees with the balloon catheter 1 at the end. A non-compliant material is selected, and there is no neck between the two balloons, which are blow-molded separately and tightly sleeved on the balloon catheter 1. The positioning balloon 2 and the olive-shaped balloon 3 are at an angle of 45 degrees with the balloon catheter 1 at the end, which is easy to slide and avoid damage to the internal urethral sphincter and the external urethral sphincter.

[0069] The prostate drug delivery balloon treatment using an olive-shaped balloon in this embodiment only requires the balloon to contact the prostate to complete the operation, and the treatment process is simple. At the same time, separate pressurized liquid channels are set for the positioning balloon and the olive-shaped balloon to ensure safety and controllability. The two balloon ends are set at an angle of 45 degrees to the balloon catheter 1, are made of non-compliant materials, and the balloon is retracted into the balloon sheath after the drug delivery is completed. The setting can further improve the safety of the operation and ensure excellent surgical results.

[0070] The above description is merely an exemplary embodiment of the present disclosure and is not intended to limit the protection scope of the present disclosure. The protection scope of the present disclosure is determined by the appended claims.

Claims

1. A balloon assembly with a guidewire channel for administering drugs to the prostate, comprising: A balloon catheter, a positioning balloon fixedly arranged at the distal end of the balloon catheter, and an olive-shaped balloon adjacent to the positioning balloon and fixedly arranged on the balloon catheter. The balloon catheter has a guidewire channel and a pressurized liquid channel, wherein the pressurized liquid channel is connected to the positioning balloon and the olive-shaped balloon, and the guidewire channel is not connected to the pressurized liquid channel. The drug delivery balloon assembly further comprises a sheath tube for accommodating the positioning balloon, the olive-shaped balloon and a corresponding balloon catheter, so that the positioning balloon and the olive-shaped balloon can reciprocate in the sheath tube, and the outer diameter of the sheath tube is 2 mm to 10 mm. A drug composition layer is disposed on the outer surface of the olive-shaped balloon, Among them, the positioning balloon is used to be set in the patient's bladder for positioning the balloon catheter, the olive-shaped balloon is used to be set in the patient's prostate for dilating and administering the prostate by contacting the inner wall of the prostate, the length of the sheath is greater than the length of the balloon catheter in the patient's body when in use, and is less than the length of the balloon catheter, and when the sheath is withdrawn proximally relative to the balloon catheter, at least the positioning balloon and the olive-shaped balloon are exposed.

2. The balloon assembly according to claim 1, wherein: The outer diameter of the sheath tube is 4 mm to 8 mm.

3. The balloon assembly according to claim 1, wherein: The outer diameter of the sheath tube is 5 mm to 7 mm.

4. The balloon assembly according to claim 1, wherein: It also includes a balloon connecting portion arranged between the positioning balloon and the olive-shaped balloon, and the outer diameter of the balloon connecting portion is smaller than the outer diameters of the positioning balloon and the olive-shaped balloon.

5. The balloon assembly according to claim 1, wherein: The positioning balloon and the olive-shaped balloon are directly connected.

6. The balloon assembly according to claim 1, wherein: The pressurized fluid channel includes a positioning balloon pressurized fluid channel and an olive-shaped balloon pressurized fluid channel, the positioning balloon pressurized fluid channel and the olive-shaped balloon pressurized fluid channel are not connected to each other, the positioning balloon pressurized fluid channel has a positioning balloon pressurized fluid channel through hole connected to the positioning balloon, and the olive-shaped balloon pressurized fluid channel has an olive-shaped balloon pressurized fluid channel through hole connected to the olive-shaped balloon.

7. The balloon assembly according to claim 1, wherein: The sheath has a front sheath portion and a rear sheath portion, the front sheath portion is made of a low-strength material, the length of the front sheath portion is greater than 2 mm and shorter than the distance between the two balloons, and the rear sheath portion is made of a high-strength material, so that when the positioning balloon and the olive-shaped balloon are in the rear sheath portion, the balloons cannot be expanded by applying pressure.

8. The balloon assembly according to claim 1, wherein: The inner diameter of the sheath tube is such that when the positioning balloon and the olive-shaped balloon are expanded and then contracted under the pressure of the pressurized fluid, the positioning balloon and the olive-shaped balloon can be retracted into the sheath tube.

9. The balloon assembly according to claim 1, wherein: The longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon independently have convex arc-shaped contours at the ends.

10. The balloon assembly according to claim 1, wherein: The longitudinal sections of the outer surfaces of the positioning balloon and the olive-shaped balloon independently form an angle of 30 to 50 degrees with the balloon catheter at the end.

11. The balloon assembly according to claim 1, wherein: The radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 6-40 mm.

12. The balloon assembly according to claim 1, wherein: The radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 10-35 mm.

13. The balloon assembly according to claim 1, wherein: The radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 12-30 mm.

14. The balloon assembly according to claim 1, wherein: The radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 15-25 mm.

15. The balloon assembly according to claim 1, wherein: The radial dimensions of the positioning balloon and the olive-shaped balloon when expanded are independently 16-23 mm.

16. The balloon assembly according to claim 7, wherein: The inner diameter of the sheath tube is such that when the positioning balloon and the olive-shaped balloon are expanded and then contracted under the pressure of the pressurized fluid, the positioning balloon and the olive-shaped balloon can be retracted into the sheath tube.

17. The balloon assembly according to any one of claims 1-16, wherein the positioning balloon and the olive-shaped balloon are both non-compliant balloons or low-compliant balloons.

Citation Information

Cited By

  • Combined urethral catheterization device for nursing in department of cardiology and nephrology

    CN121534290A